Effective  ||| S:0 E:10 ||| JJ
Constipation  ||| S:10 E:23 ||| NNP
Treatment  ||| S:23 E:33 ||| NNP
Changes  ||| S:33 E:41 ||| NNP
More  ||| S:41 E:46 ||| RBR
Than  ||| S:46 E:51 ||| IN
Bowel  ||| S:51 E:57 ||| NNP
Frequency ||| S:57 E:66 ||| NNP
:  ||| S:66 E:68 ||| :
A  ||| S:68 E:70 ||| DT
Systematic  ||| S:70 E:81 ||| NNP
Review  ||| S:81 E:88 ||| NNP
and  ||| S:88 E:92 ||| CC
Meta-Analysis  ||| S:92 E:106 ||| JJ
The  ||| S:106 E:110 ||| DT
marketing  ||| S:110 E:120 ||| NN
of  ||| S:120 E:123 ||| IN
newer  ||| S:123 E:129 ||| JJR
agents  ||| S:129 E:136 ||| NNS
for  ||| S:136 E:140 ||| IN
treatment  ||| S:140 E:150 ||| NN
of  ||| S:150 E:153 ||| IN
constipation  ||| S:153 E:166 ||| NN
and  ||| S:166 E:170 ||| CC
irritable  ||| S:170 E:180 ||| JJ
bowel  ||| S:180 E:186 ||| JJ
syndrome  ||| S:186 E:195 ||| NN
with  ||| S:195 E:200 ||| IN
constipation  ||| S:200 E:213 ||| NNS
( ||| S:213 E:214 ||| -LRB-
IBS-C ||| S:214 E:219 ||| NNP
)  ||| S:219 E:221 ||| -RRB-
emphasize  ||| S:221 E:231 ||| JJ
improvements  ||| S:231 E:244 ||| NNS
in  ||| S:244 E:247 ||| IN
abdominal  ||| S:247 E:257 ||| JJ
pain ||| S:257 E:261 ||| NN
.  ||| S:261 E:263 ||| .
However ||| S:263 E:270 ||| RB
,  ||| S:270 E:272 ||| ,
it  ||| S:272 E:275 ||| PRP
is  ||| S:275 E:278 ||| VBZ
not  ||| S:278 E:282 ||| RB
clear  ||| S:282 E:288 ||| JJ
whether  ||| S:288 E:296 ||| IN
this  ||| S:296 E:301 ||| DT
observation  ||| S:301 E:313 ||| NN
reflects  ||| S:313 E:322 ||| VBZ
a  ||| S:322 E:324 ||| DT
unique  ||| S:324 E:331 ||| JJ
visceral  ||| S:331 E:340 ||| JJ
analgesic  ||| S:340 E:350 ||| JJ
effect  ||| S:350 E:357 ||| NN
of  ||| S:357 E:360 ||| IN
these  ||| S:360 E:366 ||| DT
agents  ||| S:366 E:373 ||| NNS
or  ||| S:373 E:376 ||| CC
is  ||| S:376 E:379 ||| VBZ
a  ||| S:379 E:381 ||| DT
general  ||| S:381 E:389 ||| JJ
feature  ||| S:389 E:397 ||| NN
of  ||| S:397 E:400 ||| IN
effective  ||| S:400 E:410 ||| JJ
laxation ||| S:410 E:418 ||| NN
.  ||| S:418 E:420 ||| .
We  ||| S:420 E:423 ||| PRP
sought  ||| S:423 E:430 ||| VBD
to  ||| S:430 E:433 ||| TO
determine  ||| S:433 E:443 ||| VB
the  ||| S:443 E:447 ||| DT
relationship  ||| S:447 E:460 ||| NN
between  ||| S:460 E:468 ||| IN
improvements  ||| S:468 E:481 ||| NNS
in  ||| S:481 E:484 ||| IN
bowel  ||| S:484 E:490 ||| JJ
frequency  ||| S:490 E:500 ||| NN
and  ||| S:500 E:504 ||| CC
decreases  ||| S:504 E:514 ||| NNS
in  ||| S:514 E:517 ||| IN
abdominal  ||| S:517 E:527 ||| JJ
pain  ||| S:527 E:532 ||| NN
in  ||| S:532 E:535 ||| IN
clinical  ||| S:535 E:544 ||| JJ
trials  ||| S:544 E:551 ||| NNS
of  ||| S:551 E:554 ||| IN
patients  ||| S:554 E:563 ||| NNS
with  ||| S:563 E:568 ||| IN
constipation  ||| S:568 E:581 ||| NN
or  ||| S:581 E:584 ||| CC
IBS-C ||| S:584 E:589 ||| JJ
.  ||| S:589 E:591 ||| .
We  ||| S:591 E:594 ||| PRP
searched  ||| S:594 E:603 ||| VBD
PubMed  ||| S:603 E:610 ||| JJ
and  ||| S:610 E:614 ||| CC
Embase  ||| S:614 E:621 ||| NNP
databanks  ||| S:621 E:631 ||| NN
for  ||| S:631 E:635 ||| IN
clinical  ||| S:635 E:644 ||| JJ
trials  ||| S:644 E:651 ||| NNS
in  ||| S:651 E:654 ||| IN
patients  ||| S:654 E:663 ||| NNS
with  ||| S:663 E:668 ||| IN
constipation  ||| S:668 E:681 ||| NN
or  ||| S:681 E:684 ||| CC
IBS-C ||| S:684 E:689 ||| JJ
,  ||| S:689 E:691 ||| ,
targeting  ||| S:691 E:701 ||| VBG
publications  ||| S:701 E:714 ||| NNS
that  ||| S:714 E:719 ||| WDT
provided  ||| S:719 E:728 ||| VBD
detailed  ||| S:728 E:737 ||| JJ
data  ||| S:737 E:742 ||| NNS
on  ||| S:742 E:745 ||| IN
bowel  ||| S:745 E:751 ||| JJ
movement  ||| S:751 E:760 ||| NN
frequency  ||| S:760 E:770 ||| NN
and  ||| S:770 E:774 ||| CC
pain  ||| S:774 E:779 ||| NN
intensity  ||| S:779 E:789 ||| NN
before  ||| S:789 E:796 ||| IN
and  ||| S:796 E:800 ||| CC
after  ||| S:800 E:806 ||| IN
an  ||| S:806 E:809 ||| DT
intervention ||| S:809 E:821 ||| NN
.  ||| S:821 E:823 ||| .
We  ||| S:823 E:826 ||| PRP
abstracted  ||| S:826 E:837 ||| VBD
the  ||| S:837 E:841 ||| DT
results  ||| S:841 E:849 ||| NNS
and  ||| S:849 E:853 ||| CC
performed  ||| S:853 E:863 ||| VBD
meta-analytic  ||| S:863 E:877 ||| JJ
and  ||| S:877 E:881 ||| CC
meta-regression  ||| S:881 E:897 ||| JJ
analyses ||| S:897 E:905 ||| NNS
.  ||| S:905 E:907 ||| .
Twenty-seven  ||| S:907 E:920 ||| JJ
trials  ||| S:920 E:927 ||| NNS
( ||| S:927 E:928 ||| -LRB-
16  ||| S:928 E:931 ||| CD
constipation  ||| S:931 E:944 ||| NNS
and  ||| S:944 E:948 ||| CC
11  ||| S:948 E:951 ||| CD
IBS ||| S:951 E:954 ||| NNP
)  ||| S:954 E:956 ||| -RRB-
met  ||| S:956 E:960 ||| VBD
entry  ||| S:960 E:966 ||| NN
criteria ||| S:966 E:974 ||| NNS
.  ||| S:974 E:976 ||| .
Baseline  ||| S:976 E:985 ||| JJ
weekly  ||| S:985 E:992 ||| JJ
bowel  ||| S:992 E:998 ||| JJ
movement  ||| S:998 E:1007 ||| NN
frequency  ||| S:1007 E:1017 ||| NN
was  ||| S:1017 E:1021 ||| VBD
low  ||| S:1021 E:1025 ||| JJ
with  ||| S:1025 E:1030 ||| IN
2.35  ||| S:1030 E:1035 ||| CD
( ||| S:1035 E:1036 ||| -LRB-
2.07-2.64 ||| S:1036 E:1045 ||| NNP
)  ||| S:1045 E:1047 ||| -RRB-
with  ||| S:1047 E:1052 ||| IN
differences  ||| S:1052 E:1064 ||| NNS
between  ||| S:1064 E:1072 ||| IN
constipation  ||| S:1072 E:1085 ||| NNS
( ||| S:1085 E:1086 ||| -LRB-
2.00  ||| S:1086 E:1091 ||| NNP
[ ||| S:1091 E:1092 ||| -LRB-
1.62-2.38 ||| S:1092 E:1101 ||| NNP
] ||| S:1101 E:1102 ||| -RRB-
)  ||| S:1102 E:1104 ||| -RRB-
and  ||| S:1104 E:1108 ||| CC
IBS-C  ||| S:1108 E:1114 ||| NNP
( ||| S:1114 E:1115 ||| -LRB-
2.77  ||| S:1115 E:1120 ||| CD
[ ||| S:1120 E:1121 ||| -LRB-
2.40-3.14 ||| S:1121 E:1130 ||| NNP
] ||| S:1130 E:1131 ||| -RRB-
;  ||| S:1131 E:1133 ||| :
Q  ||| S:1133 E:1135 ||| NNP
=  ||| S:1135 E:1137 ||| SYM
8.18 ||| S:1137 E:1141 ||| CD
;  ||| S:1141 E:1143 ||| :
P  ||| S:1143 E:1145 ||| NN
=  ||| S:1145 E:1147 ||| SYM
0.002 ||| S:1147 E:1152 ||| CD
) ||| S:1152 E:1153 ||| -RRB-
.  ||| S:1153 E:1155 ||| .
Studies  ||| S:1155 E:1163 ||| NNS
reported  ||| S:1163 E:1172 ||| VBD
moderate  ||| S:1172 E:1181 ||| JJ
pain  ||| S:1181 E:1186 ||| NN
levels  ||| S:1186 E:1193 ||| NNS
( ||| S:1193 E:1194 ||| -LRB-
2.12  ||| S:1194 E:1199 ||| NNP
[ ||| S:1199 E:1200 ||| -LRB-
1.81-2.42 ||| S:1200 E:1209 ||| NNP
] ||| S:1209 E:1210 ||| -RRB-
)  ||| S:1210 E:1212 ||| -RRB-
with  ||| S:1212 E:1217 ||| IN
comparable  ||| S:1217 E:1228 ||| JJ
baseline  ||| S:1228 E:1237 ||| NN
levels  ||| S:1237 E:1244 ||| NNS
in  ||| S:1244 E:1247 ||| IN
constipation  ||| S:1247 E:1260 ||| NNS
( ||| S:1260 E:1261 ||| -LRB-
2.02  ||| S:1261 E:1266 ||| CD
[ ||| S:1266 E:1267 ||| -LRB-
1.63-2.42 ||| S:1267 E:1276 ||| NNP
] ||| S:1276 E:1277 ||| -RRB-
)  ||| S:1277 E:1279 ||| -RRB-
and  ||| S:1279 E:1283 ||| CC
IBS-C  ||| S:1283 E:1289 ||| NNP
( ||| S:1289 E:1290 ||| -LRB-
2.35  ||| S:1290 E:1295 ||| CD
[ ||| S:1295 E:1296 ||| -LRB-
2.10-2.60 ||| S:1296 E:1305 ||| NNP
] ||| S:1305 E:1306 ||| -RRB-
;  ||| S:1306 E:1308 ||| :
Q  ||| S:1308 E:1310 ||| NNP
=  ||| S:1310 E:1312 ||| SYM
1.92 ||| S:1312 E:1316 ||| CD
;  ||| S:1316 E:1318 ||| :
P  ||| S:1318 E:1320 ||| NN
=  ||| S:1320 E:1322 ||| SYM
0.167 ||| S:1322 E:1327 ||| CD
) ||| S:1327 E:1328 ||| -RRB-
.  ||| S:1328 E:1330 ||| .
Treatments  ||| S:1330 E:1341 ||| NNS
increased  ||| S:1341 E:1351 ||| VBD
bowel  ||| S:1351 E:1357 ||| JJ
frequency  ||| S:1357 E:1367 ||| NN
by  ||| S:1367 E:1370 ||| IN
2.17  ||| S:1370 E:1375 ||| CD
[ ||| S:1375 E:1376 ||| -LRB-
1.88-2.47 ||| S:1376 E:1385 ||| NNP
]  ||| S:1385 E:1387 ||| -RRB-
and  ||| S:1387 E:1391 ||| CC
lowered  ||| S:1391 E:1399 ||| VBD
pain  ||| S:1399 E:1404 ||| NN
ratings  ||| S:1404 E:1412 ||| NNS
by  ||| S:1412 E:1415 ||| IN
0.58  ||| S:1415 E:1420 ||| NNP
[ ||| S:1420 E:1421 ||| -LRB-
0.49-0.68 ||| S:1421 E:1430 ||| NNP
] ||| S:1430 E:1431 ||| -RRB-
.  ||| S:1431 E:1433 ||| .
Meta-regression  ||| S:1433 E:1449 ||| NNP
demonstrated  ||| S:1449 E:1462 ||| VBD
a  ||| S:1462 E:1464 ||| DT
significant  ||| S:1464 E:1476 ||| JJ
correlation  ||| S:1476 E:1488 ||| NN
between  ||| S:1488 E:1496 ||| IN
treatment-induced  ||| S:1496 E:1514 ||| JJ
increases  ||| S:1514 E:1524 ||| NNS
in  ||| S:1524 E:1527 ||| IN
bowel  ||| S:1527 E:1533 ||| JJ
frequency  ||| S:1533 E:1543 ||| NN
and  ||| S:1543 E:1547 ||| CC
decreased  ||| S:1547 E:1557 ||| JJ
pain  ||| S:1557 E:1562 ||| NN
ratings ||| S:1562 E:1569 ||| NNS
.  ||| S:1569 E:1571 ||| .
Our  ||| S:1571 E:1575 ||| PRP$
analysis  ||| S:1575 E:1584 ||| NN
suggests  ||| S:1584 E:1593 ||| VBZ
that  ||| S:1593 E:1598 ||| DT
reduction  ||| S:1598 E:1608 ||| NN
of  ||| S:1608 E:1611 ||| IN
abdominal  ||| S:1611 E:1621 ||| JJ
pain  ||| S:1621 E:1626 ||| NN
observed  ||| S:1626 E:1635 ||| VBD
in  ||| S:1635 E:1638 ||| IN
clinical  ||| S:1638 E:1647 ||| JJ
trials  ||| S:1647 E:1654 ||| NNS
of  ||| S:1654 E:1657 ||| IN
constipation  ||| S:1657 E:1670 ||| NN
and  ||| S:1670 E:1674 ||| CC
IBS-C  ||| S:1674 E:1680 ||| NNP
is  ||| S:1680 E:1683 ||| VBZ
associated  ||| S:1683 E:1694 ||| VBN
with  ||| S:1694 E:1699 ||| IN
laxation ||| S:1699 E:1707 ||| NN
,  ||| S:1707 E:1709 ||| ,
and  ||| S:1709 E:1713 ||| CC
may  ||| S:1713 E:1717 ||| MD
not  ||| S:1717 E:1721 ||| RB
require  ||| S:1721 E:1729 ||| VB
specific  ||| S:1729 E:1738 ||| JJ
drug  ||| S:1738 E:1743 ||| NN
mechanisms ||| S:1743 E:1753 ||| NNS
,  ||| S:1753 E:1755 ||| ,
thus  ||| S:1755 E:1760 ||| RB
arguing  ||| S:1760 E:1768 ||| VBG
against  ||| S:1768 E:1776 ||| IN
a  ||| S:1776 E:1778 ||| DT
unique  ||| S:1778 E:1785 ||| JJ
advantage  ||| S:1785 E:1795 ||| NN
of  ||| S:1795 E:1798 ||| IN
newer  ||| S:1798 E:1804 ||| JJR
agents  ||| S:1804 E:1811 ||| NNS
over  ||| S:1811 E:1816 ||| IN
traditional  ||| S:1816 E:1828 ||| JJ
laxatives  ||| S:1828 E:1838 ||| NNS
in  ||| S:1838 E:1841 ||| IN
the  ||| S:1841 E:1845 ||| DT
treatment  ||| S:1845 E:1855 ||| NN
of  ||| S:1855 E:1858 ||| IN
constipation  ||| S:1858 E:1871 ||| NN
and  ||| S:1871 E:1875 ||| CC
IBS-C ||| S:1875 E:1880 ||| JJ
.  ||| S:1880 E:1882 ||| .
